secwatch.observer — SEC 8-K summary
======================================

Issuer:     Vistagen Therapeutics, Inc. (VTGN)
CIK:        0001411685
Form:       8-K
Filed at:   2021-07-08T23:59:59+00:00
Accession:  0001654954-21-007757
Event type: leadership
Sentiment:  neutral
Materiality: 0.30
Item codes: 5.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

VistaGen appoints healthcare attorney Mary L. Rotunno to board
--------------------------------------------------------------

- Mary L. Rotunno, J.D., appointed to VistaGen's Board of Directors effective July 6, 2021.
- Rotunno currently serves as General Counsel of El Camino Health, a $1B revenue health system.
- She is considered an independent director under Nasdaq listing rules.
- Company entered into a standard indemnification agreement with Rotunno.
- Rotunno brings over 30 years of healthcare legal and nursing experience.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1411685/000165495421007757/0001654954-21-007757-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1411685/000165495421007757/vtgn8k_07062021.htm
  HTML page:      https://secwatch.observer/filing/0001654954-21-007757

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer